Viewing Study NCT05541627


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2025-12-26 @ 4:12 AM
Study NCT ID: NCT05541627
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-18
First Post: 2022-09-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate AB-1001 Striatal Administration in Adults With Early Manifest Huntington's Disease
Sponsor: Brainvectis, a subsidiary of Asklepios BioPharmaceutical, Inc. (AskBio)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module